Osteoporosis in patients taking selective serotonin reuptake inhibitors: a focus on fracture outcome (Q34432269)

2 August 2017

title

Osteoporosis in patients taking selective serotonin reuptake inhibitors: a focus on fracture outcome (English)

1 reference

2 August 2017

0 references

0 references

1 reference

2

Jean-Yves Reginster

1 reference

2 August 2017

1

Olivier Bruyère

1 reference

2 August 2017

publication date

5 August 2014

1 reference

2 August 2017

1 reference

2 August 2017

volume

48

1 reference

2 August 2017

issue

1

1 reference

2 August 2017

page(s)

65-68

1 reference

Prevalence, treatment, and control of depressive symptoms in the United States: results from the National Health and Nutrition Examination Survey (NHANES), 2005-2008.

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0357-0

Explaining the rise in antidepressant prescribing: a descriptive study using the general practice research database.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0357-0

Trends in primary care antidepressant prescribing 1995-2007: a longitudinal population database analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0357-0

Antidepressant medications and osteoporosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0357-0

Fortnightly review: drug treatment of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0357-0

Effects of selective serotonin reuptake inhibitors on bone health in adults: time for recommendations about screening, prevention and management?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0357-0

The two faces of serotonin in bone biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0357-0

Use of antidepressants and rates of hip bone loss in older women: the study of osteoporotic fractures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0357-0

Selective serotonin reuptake inhibitor use and bone mineral density in women with a history of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0357-0

Association of low bone mineral density with selective serotonin reuptake inhibitor use by older men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0357-0

Risk of fractures with selective serotonin-reuptake inhibitors or tricyclic antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0357-0

SSRIs, bone mineral density, and risk of fractures--a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0357-0

Risk of nonvertebral fractures among elderly postmenopausal women using antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0357-0

Increased risk of hip fracture among older people using antidepressant drugs: data from the Norwegian Prescription Database and the Norwegian Hip Fracture Registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0357-0

Excess risk of hip fractures attributable to the use of antidepressants in five European countries and the USA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0357-0

Antidepressant use and 10-year incident fracture risk: the population-based Canadian Multicentre Osteoporosis Study (CaMoS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0357-0

Antidepressants and fracture risk in older adults: a comparative safety analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0357-0

New understanding and treatments for osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0357-0

New advances in imaging osteoporosis and its complications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0357-0

Tricyclic antidepressant use and risk of fractures: a meta-analysis of cohort and case-control studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0357-0

Relationship between use of antidepressants and risk of fractures: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0357-0

Use of selective serotonin reuptake inhibitors and risk of fracture: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0357-0

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0357-0

The missed lessons of Sir Austin Bradford Hill

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0357-0

Use of anti-depressants and the risk of fracture of the hip or femur.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0357-0

Fractures in users of antidepressants and anxiolytics and sedatives: effects of age and dose

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0357-0

The joint action on healthy life years (JA: EHLEIS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0357-0

Skeletal effects of serotonin (5-hydroxytryptamine) transporter inhibition: evidence from clinical studies.

21 January 2018

1 reference

12 December 2020

Depression: major problem for public health

1 reference

12 December 2020

Prevalence of mental disorders in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project

1 reference

12 December 2020

Depressive vulnerability is not an independent risk factor for osteoporosis in postmenopausal women.

1 reference

12 December 2020

10.1007/S12020-014-0357-0

Identifiers

DOI

1 reference

2 August 2017

1 reference